carbamazepine has been researched along with albendazole in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.70) | 18.2507 |
2000's | 7 (30.43) | 29.6817 |
2010's | 11 (47.83) | 24.3611 |
2020's | 3 (13.04) | 2.80 |
Authors | Studies |
---|---|
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Connelly, MC; Guiguemde, WA; Guy, RK; Nwaka, S; Sigal, M; Zhang, Y; Zhu, F | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Li, F; Liu, Y; Wang, W; Wu, L; Yan, B; Zhang, Q; Zhou, H; Zhu, H | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bassett, R; Budhraja, A; Das, S; Ling, T; Maier, J; Opferman, JT; Potts, MB; Rankovic, Z; Rivas, F; Shelat, A | 1 |
Ahn, KJ; Anderson, MO; Baum, J; Belanger, B; Chaplan, CA; Cheung, A; Churchyard, A; Crespo, B; DiBernardo, C; Eagon, S; Eribez, K; Falade, MO; Gamo, FJ; García-Barbazán, I; Guy, RK; Hammill, JT; Kashtanova, AS; Kim, K; Kimball, JJ; Koch, G; Laleu, B; Lazaro, H; Loop, L; Mittal, N; Rice, AL; Sigal, M; Takahashi, R; Tryhorn, JE; Wilkinson, SP; Winzeler, EA; Yniguez, K | 1 |
Asakawa, AH; Brockmeyer, F; Casandra, D; Huang, L; Kyle, DE; LaCrue, AN; Maher, SP; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Padin-Irizarry, V; Parvatkar, PT; Sakhno, YI; Zhao, Y | 1 |
DiBernardo, C; Eagon, S; Falade, MO; Fitzsimmons, K; Glidden, JE; Guy, RK; Hammill, JT; Kimball, JJ; Law, J; Manjunath, A; Nguyen, B; Rice, AL; Sienko, N; Thompson, K; Wilkinson, SP | 1 |
del Brutto, OH | 1 |
Ray, M; Singhi, P | 1 |
Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM | 1 |
Jain, VK; Phadke, RV; Sharma, K; Varma, A; Wahi, J | 1 |
Grossi, P; Kanter, Rd; Monaci, S; Monshouwer, M; Turlizzi, E; Vignati, L | 1 |
Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A | 1 |
Asnis, D; Bern, C; Bishop, H; Di John, D; Garcia, HH; Garcia, MA; Grossmann, R; Kazakov, J; Lee, L; McAuliffe, I; Toronjadze, T | 1 |
Gaytán-Martínez, LA; Pérez-Gómez, HR; Ramos-Zúñiga, R; Rochín-Mozqueda, A; Soto-Rodríguez, S; Vega-Ruiz, B | 1 |
1 review(s) available for carbamazepine and albendazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for carbamazepine and albendazole
Article | Year |
---|---|
Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Female; Humans; Isomerism; Male; Neurocysticercosis; Phenobarbital; Phenytoin | 2002 |
Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Carbamazepine; Cerebral Cortex; Child; Child, Preschool; Epilepsy; Female; Humans; Male; Middle Aged; Neurocysticercosis; Phenytoin; Prospective Studies; Recurrence; Seizures; Tomography, X-Ray Computed | 2008 |
20 other study(ies) available for carbamazepine and albendazole
Article | Year |
---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Synthesis and structure-activity relationships of antimalarial 4-oxo-3-carboxyl quinolones.
Topics: Animals; Antimalarials; Cell Line; Cell Survival; Drug Resistance; Erythrocytes; Escherichia coli; Humans; Indicators and Reagents; Mefloquine; Membranes, Artificial; Permeability; Plasmodium falciparum; Quinolones; Solubility; Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2014 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; High-Throughput Screening Assays; Humans; Molecular Structure; Small Molecule Libraries; Solubility; Structure-Activity Relationship; Thiazolidines; Water | 2015 |
Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Drug Evaluation, Preclinical; Enzyme Induction; Heterocyclic Compounds; Humans; Leukemia; Mice; Small Molecule Libraries; Therapeutic Index | 2019 |
Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-
Topics: Antimalarials; Cell Line; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyridines; Structure-Activity Relationship | 2020 |
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; Half-Life; Hydrogen-Ion Concentration; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Prodrugs; Quinolones; Solubility; Structure-Activity Relationship | 2021 |
Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives.
Topics: Antimalarials; Cell Proliferation; Chloroquine; Dose-Response Relationship, Drug; Fibroblasts; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |
[Neurocysticercosis in children: clinical and radiological analysis and prognostic factors in 54 patients].
Topics: Adolescent; Albendazole; Anthelmintics; Anticonvulsants; Brain; Brain Diseases; Carbamazepine; Child; Child, Preschool; Cysticercosis; Epilepsy, Tonic-Clonic; Female; Humans; Male; Phenytoin; Prognosis; Tomography, X-Ray Computed | 1997 |
Focal seizures with single small ring-enhancing lesion.
Topics: Acute Disease; Albendazole; Anthelmintics; Anticonvulsants; Brain Edema; Carbamazepine; Diagnosis, Differential; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Magnetic Resonance Imaging; Neurocysticercosis; Tomography, X-Ray Computed | 1999 |
Migraine-like visual hallucinations in occipital lesions of cysticercosis.
Topics: Adolescent; Adult; Albendazole; Anticonvulsants; Antiprotozoal Agents; Carbamazepine; Drug Therapy, Combination; Glucocorticoids; Hallucinations; Humans; Magnetic Resonance Imaging; Male; Migraine Disorders; Neurocysticercosis; Occipital Lobe; Prednisolone; Tomography, X-Ray Computed | 2002 |
An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.
Topics: Adenosine Triphosphate; Albendazole; Amitriptyline; Animals; Buthionine Sulfoximine; Carbamazepine; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Chromans; Coculture Techniques; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Enzyme Activation; Flutamide; Glutathione; Humans; Isoniazid; Microsomes; Ochratoxins; Piperazines; Quinidine; Substrate Specificity; Tamoxifen; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Toxicity Tests; Triazolam; Troglitazone; Xenobiotics | 2005 |
Neurocysticercosis in the infant of a pregnant mother with a tapeworm.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Anticonvulsants; Carbamazepine; Dexamethasone; Feces; Female; Humans; Infant; Male; Neurocysticercosis; Niclosamide; Pregnancy; Pregnancy Complications, Parasitic; Seizures; Taenia solium | 2009 |
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports].
Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram; Delayed Diagnosis; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Headache; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurocysticercosis; Oxcarbazepine; Panic Disorder; Perphenazine; Prednisone | 2015 |